Skye Bioscience (NASDAQ: SKYE)
$3.69
(1.9%)
$0.07
Price as of June 25, 2025, 4:00 p.m. ET
Skye Bioscience Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Skye Bioscience Company Info
Skye Bioscience, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of cannabinoid-based therapeutics. It focuses on the treatment of a spectrum of diseases, as well as utilizing bioengineering in drug design. Its product pipeline includes SBI-100 and SBI-200. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.